|
Volumn 44, Issue 4, 2012, Pages 361-362
|
Zhou et al. reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENYLATE KINASE;
INCRETIN;
METFORMIN;
OCTAMER TRANSCRIPTION FACTOR 1;
PROTEIN P53;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);
CELL CYCLE PROTEIN;
DNA BINDING PROTEIN;
PROTEIN SERINE THREONINE KINASE;
TUMOR SUPPRESSOR PROTEIN;
DOUBLE STRANDED DNA BREAK;
DRUG ACTIVITY;
DRUG RESPONSE;
DRUG UPTAKE;
GENE LOCUS;
GENE MUTATION;
GENETIC ASSOCIATION;
GENETIC VARIABILITY;
GLUCONEOGENESIS;
GLUCOSE UTILIZATION;
HORMONE RELEASE;
LETTER;
NONHUMAN;
PHARMACOGENETICS;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
ANIMAL;
GENETICS;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
ANIMALS;
CELL CYCLE PROTEINS;
DIABETES MELLITUS, TYPE 2;
DNA-BINDING PROTEINS;
HUMANS;
METFORMIN;
PROTEIN-SERINE-THREONINE KINASES;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 84859359931
PISSN: 10614036
EISSN: 15461718
Source Type: Journal
DOI: 10.1038/ng.2234 Document Type: Letter |
Times cited : (15)
|
References (15)
|